AmerisourceBergen Top Management

ABCDelisted Stock  USD 191.45  1.55  0.80%   
AmerisourceBergen employs about 46 K people. The company is managed by 22 executives with a total tenure of roughly 179 years, averaging almost 8.0 years of service per executive, having 2090.91 employees per reported executive. Evaluation of AmerisourceBergen's management performance can provide insight into the firm performance.
Steven Collis  CEO
CEO and President Director and Member of Executive Committee
James Cleary  President
Executive Vice President and Presidentident - MWI Veterinary Supply
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

AmerisourceBergen Management Team Effectiveness

The company has Return on Asset of 0.027 % which means that on every $100 spent on assets, it made $0.027 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 2.3366 %, implying that it generated $2.3366 on every 100 dollars invested. AmerisourceBergen's management efficiency ratios could be used to measure how well AmerisourceBergen manages its routine affairs as well as how well it operates its assets and liabilities.

AmerisourceBergen Workforce Comparison

AmerisourceBergen is rated second in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 193,929. AmerisourceBergen totals roughly 46,000 in number of employees claiming about 24% of equities under Health Care industry.
The company has Net Profit Margin of 0.01 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.01 %, which entails that for every 100 dollars of revenue, it generated $0.01 of operating income.

AmerisourceBergen Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific AmerisourceBergen insiders, such as employees or executives, is commonly permitted as long as it does not rely on AmerisourceBergen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, AmerisourceBergen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

AmerisourceBergen Notable Stakeholders

An AmerisourceBergen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as AmerisourceBergen often face trade-offs trying to please all of them. AmerisourceBergen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting AmerisourceBergen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Steven CollisCEO and President Director and Member of Executive CommitteeProfile
James ClearyExecutive Vice President and Presidentident - MWI Veterinary SupplyProfile
Robert MauchExecutive Vice President, Group President - Pharmaceutical Distribution & Strategic Global SourcingProfile
Bennett MurphyVice President Investor RelationsProfile
John ChouExecutive Vice President, Chief Legal Officer and SecretaryProfile
Gina ClarkExecutive Vice President, Chief Communications & Administration OfficerProfile
Kathy GaddesChief Human Resource Officer, Executive Vice PresidentProfile
Silvana BattagliaChief Human Resource Officer, Executive Vice PresidentProfile
Leslie DonatoExecutive Vice President and Chief Strategy OfficerProfile
Lazarus KrikorianSenior Vice President Principal Accounting Officer, Corporate ControllerProfile
Ornella BarraDirectorProfile
Richard GochnauerIndependent DirectorProfile
Lon GreenbergIndependent DirectorProfile
Dennis NallyIndependent DirectorProfile
Kathleen HyleIndependent DirectorProfile
Jane HenneyLead Independent DirectorProfile
Henry McGeeIndependent DirectorProfile
Michael LongIndependent DirectorProfile
PharmD MauchEx COOProfile
Lonie HaynesSenior Vice President Chief Diversity and Inclusion OfficerProfile
D DurcanIndependent DirectorProfile
Elizabeth CampbellSenior Vice President and Deputy General CounselProfile

About AmerisourceBergen Management Performance

The success or failure of an entity such as AmerisourceBergen often depends on how effective the management is. AmerisourceBergen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of AmerisourceBergen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the AmerisourceBergen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
AmerisourceBergen Corporation sources and distributes pharmaceutical products. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania. Amerisourcebergen operates under Medical Distribution classification in the United States and is traded on New York Stock Exchange. It employs 000 people.
Please note, the presentation of AmerisourceBergen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AmerisourceBergen's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AmerisourceBergen's management manipulating its earnings.

AmerisourceBergen Workforce Analysis

Traditionally, organizations such as AmerisourceBergen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare AmerisourceBergen within its industry.

AmerisourceBergen Manpower Efficiency

Return on AmerisourceBergen Manpower

Revenue Per Employee5.2M
Revenue Per Executive10.8B
Net Income Per Employee36.2K
Net Income Per Executive75.8M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in AmerisourceBergen Stock

If you are still planning to invest in AmerisourceBergen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AmerisourceBergen's history and understand the potential risks before investing.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity